Detalhe da pesquisa
1.
Discovery of a potent and highly selective PDK1 inhibitor via fragment-based drug discovery.
Bioorg Med Chem Lett
; 21(10): 3078-83, 2011 May 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-21459573
2.
Antibody blockade of the Cripto CFC domain suppresses tumor cell growth in vivo.
J Clin Invest
; 112(4): 575-87, 2003 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-12925698
3.
Structures of human Bruton's tyrosine kinase in active and inactive conformations suggest a mechanism of activation for TEC family kinases.
Protein Sci
; 19(3): 429-39, 2010 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-20052711
4.
Growth factor induction of Cripto-1 shedding by glycosylphosphatidylinositol-phospholipase D and enhancement of endothelial cell migration.
J Biol Chem
; 282(43): 31643-55, 2007 Oct 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-17720976
5.
An intermediate pH unfolding transition abrogates the ability of IgE to interact with its high affinity receptor FcepsilonRIalpha.
J Biol Chem
; 281(41): 30755-67, 2006 Oct 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-16905745
6.
Targeting the lymphotoxin-beta receptor with agonist antibodies as a potential cancer therapy.
Cancer Res
; 66(19): 9617-24, 2006 Oct 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-17018619
7.
Expression, purification, and characterization of rat interferon-beta, and preparation of an N-terminally PEGylated form with improved pharmacokinetic parameters.
Protein Expr Purif
; 34(2): 229-42, 2004 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-15003256